Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Press release

NextCell Pharma AB: BioStock: NextCell's CEO comments on long-term potential

NextCell Pharma

NextCell Pharma highlights the positive trends seen in the preliminary ProTrans data in adolescents, while underscoring the need to wait until the end of the trial before drawing statistical conclusions. However, the market has a strong aversion to uncertainty and reacted hard to the one-year results revealed in mid-April. BioStock spoke with CEO Mathias Svahn to gain a deeper understanding of the data.

Read the full article at biostock.se:

https://www.biostock.se/en/2025/04/nextcells-ceo-comments-on-long-term-potential/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.